FUSN — Fusion Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.83bn
- $1.67bn
- $2.07m
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Fusion Pharmaceuticals Says On April 30, 30-Day Statutory Waiting Period Under Competition Act Expired With Respect To Transaction With AstraZeneca AB
Brief: Fusion Pharmaceuticals Announces Presentation Of Interim Data From The Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 At The AACR Annual Meeting 2024
Fusion Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Live Markets: Big pharma's FOMO will lead to more radio M&A
Press Digest: Financial Times - March 20
U.S. STOCKS ON THE MOVE-US energy sector, Avis, NuScale
U.S. STOCKS ON THE MOVE-National Cinemedia, Crinetics Pharma, Nordstrom
Fusion Pharma surges on buyout deal from AstraZeneca
Newscasts - U.S. Morning Call: Investors juggle Fed nerves with AI enthusiasm
U.S. STOCKS ON THE MOVE-National Cinemedia, Madrigal Pharmaceuticals, dLocal
Newscasts - Europe Today: Speculation mounts that the ECB will start cutting rates in June
Brief: Fusion Pharmaceuticals Says Deal Provides For Payment By Fusion To Astrazeneca AB Termination Fee Of $71.7 Million If Deal Terminated In Some Circumstances
Deals of the day-Mergers and acquisitions
Fusion Pharma surges on about $2 bln buyout deal from AstraZeneca
UK Stocks-Factors to watch on March 19 (updated)